Superior Planning, LLC’s Eton Pharmaceutcials ETON Stock Holding History

Superior Planning, LLC’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.63K	Buy	+51	New	+$2.59K	﹤0.01%	1468

Other funds holding ETON

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Lumbard & Kellner Hollis, New Hampshire $352M AUM 38.35% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Superior Planning, LLC's ETON Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Eton Pharmaceutcials (ETON) in Q3 2026: 51 shares worth $2.63K. The stake represents ﹤0.01% of the portfolio and ranks #1468 among its holdings.

130 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

Superior Planning, LLC held 51 shares of Eton Pharmaceutcials worth $2.63K as of Q3 2026.
Eton Pharmaceutcials was a new Superior Planning, LLC position in Q3 2026.
Eton Pharmaceutcials made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1468 holding.
130 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.